DJIA 18,191.35 -23.07 -0.13%
NASDAQ 4,982.97 -4.92 -0.10%
S&P 500 2,110.78 0.04 0.00%
market minute promo

Peregrine Pharmaceuticals (NASDAQ: PPHM)

1.44 0.06 (4.35%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PPHM $1.44 4.35%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $1.42
Previous Close $1.38
Daily Range $1.40 - $1.46
52-Week Range $1.19 - $3.18
Market Cap $262.2M
P/E Ratio -5.11
Dividend (Yield) $0.00 (0.0%)
Volume 1,134,421
Average Daily Volume 927,704
Current FY EPS -$0.32




Drug Makers

Peregrine Pharmaceuticals (PPHM) Description

A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website:

News & Commentary

In Case You Missed It, Researchers May Have Discovered a New Method to Treat Cancer

We know chemotherapy kills cancer cells, but it's also an indiscriminate killer of healthy cells. According to a new study released this past week, an entirely new treatment pathway could eliminate a significant portion of healthy cell death.

Wall Street's Current Play: 'Immunotherapy Of Cancer'

IHUB Most Posted And Most Read Stocks Do Not Perform Well

Morning Market Gainers

Monday Morning Movers: Achillion Up, Regulus Down Following Drug Results

This Potentially Game-Changing Experimental Drug Could Make or Break Peregrine Pharmaceuticals

This stock could double or be cut in half -- it really just depends on how well this revolutionary cancer drug performs in a late-stage study.

Peregrine Pharmaceuticals Series E Preferred Stock Shares Cross 12% Yield Mark

Ex-Div Reminder For Peregrine Pharmaceuticals Series E Convertible Preferred Stock

Peregrine Pharmaceuticals' (PPHM) CEO Steven King on Q2 2015 Results - Earnings Call Transcript

Peregrine Pharmaceuticals (PPHM) Q2 2015 Results - Earnings Call Webcast

See More PPHM News...

PPHM's Top Competitors

PPHM $1.44 (4.35%)
Current stock: PPHM
AMGN $157.62 (-0.85%)
Current stock: AMGN
GILD $103.27 (-0.88%)
Current stock: GILD
BIIB $408.20 (-0.46%)
Current stock: BIIB